149 related articles for article (PubMed ID: 33670571)
21. Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Moss HA; Berchuck A; Neely ML; Myers ER; Havrilesky LJ
JAMA Oncol; 2018 Feb; 4(2):190-195. PubMed ID: 29222541
[TBL] [Abstract][Full Text] [Related]
22. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population.
Blyuss O; Burnell M; Ryan A; Gentry-Maharaj A; Mariño IP; Kalsi J; Manchanda R; Timms JF; Parmar M; Skates SJ; Jacobs I; Zaikin A; Menon U
Clin Cancer Res; 2018 Oct; 24(19):4726-4733. PubMed ID: 30084833
[No Abstract] [Full Text] [Related]
24. Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley J; Burnell M; Gentry-Maharaj A; Ryan A; Neophytou C; Apostolidou S; Karpinskyj C; Kalsi J; Mould T; Woolas R; Singh N; Widschwendter M; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
Gynecol Oncol; 2020 Aug; 158(2):316-322. PubMed ID: 32561125
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound screening for the early detection of ovarian cancer.
DePriest PD; DeSimone CP
J Clin Oncol; 2003 May; 21(10 Suppl):194s-199s. PubMed ID: 12743134
[TBL] [Abstract][Full Text] [Related]
26. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.
Pinsky PF; Zhu C; Skates SJ; Black A; Partridge E; Buys SS; Berg CD
Int J Cancer; 2013 May; 132(9):2127-33. PubMed ID: 23065684
[TBL] [Abstract][Full Text] [Related]
27. Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.
Rosenthal AN; Fraser L; Manchanda R; Badman P; Philpott S; Mozersky J; Hadwin R; Cafferty FH; Benjamin E; Singh N; Evans DG; Eccles DM; Skates SJ; Mackay J; Menon U; Jacobs IJ
J Clin Oncol; 2013 Jan; 31(1):49-57. PubMed ID: 23213100
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
29. The role of transvaginal ultrasound in screening for ovarian cancer.
Campbell S; Gentry-Maharaj A
Climacteric; 2018 Jun; 21(3):221-226. PubMed ID: 29490504
[TBL] [Abstract][Full Text] [Related]
30. Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS).
Barrett J; Jenkins V; Farewell V; Menon U; Jacobs I; Kilkerr J; Ryan A; Langridge C; Fallowfield L;
BJOG; 2014 Aug; 121(9):1071-9. PubMed ID: 24865441
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
[TBL] [Abstract][Full Text] [Related]
32. Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gentry-Maharaj A; Glazer C; Burnell M; Ryan A; Berry H; Kalsi J; Woolas R; Skates SJ; Campbell S; Parmar M; Jacobs I; Menon U
BMJ Open; 2017 Mar; 7(3):e011822. PubMed ID: 28264823
[TBL] [Abstract][Full Text] [Related]
33. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
Menon U; Skates SJ; Lewis S; Rosenthal AN; Rufford B; Sibley K; Macdonald N; Dawnay A; Jeyarajah A; Bast RC; Oram D; Jacobs IJ
J Clin Oncol; 2005 Nov; 23(31):7919-26. PubMed ID: 16258091
[TBL] [Abstract][Full Text] [Related]
34. Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gentry-Maharaj A; Taylor H; Kalsi J; Ryan A; Burnell M; Sharma A; Apostolidou S; Campbell S; Jacobs I; Menon U
BMJ Open; 2014 Mar; 4(3):e004421. PubMed ID: 24589827
[TBL] [Abstract][Full Text] [Related]
35. Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS).
Trembling PM; Apostolidou S; Gentry-Maharaj A; Parkes J; Ryan A; Tanwar S; Burnell M; Menon U; Rosenberg WM
BMC Public Health; 2018 Mar; 18(1):409. PubMed ID: 29587697
[TBL] [Abstract][Full Text] [Related]
36. Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Burnell M; Cox C; Ryan A; Salter LC; Gentry-Maharaj A; Parmar M; Jacobs I; Menon U
BMJ Open; 2014 Sep; 4(9):e005400. PubMed ID: 25252818
[TBL] [Abstract][Full Text] [Related]
37. Progress and challenges in screening for early detection of ovarian cancer.
Jacobs IJ; Menon U
Mol Cell Proteomics; 2004 Apr; 3(4):355-66. PubMed ID: 14764655
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer screening effectiveness: A realization from the UK Collaborative Trial of Ovarian Cancer Screening.
Pavlik EJ
Womens Health (Lond); 2016 Sep; 12(5):475-479. PubMed ID: 27595999
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
